1.

Record Nr.

UNINA9910131531803321

Autore

Alex Alexander A.

Titolo

Attrition in the pharmaceutical industry : reasons, implications, and pathways forward / / edited by Alexander Alex, C. John Harris, Dennis A. Smith

Pubbl/distr/stampa

Hoboken, New Jersey : , : Wiley, , 2016

©2016

ISBN

1-118-91434-1

1-118-81958-6

1-118-81944-6

Descrizione fisica

1 online resource (373 p.)

Disciplina

615.1068/5

Soggetti

Pharmaceutical industry - Management

Pharmaceutical industry - Capital productivity

Industrial efficiency

Drug development

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Includes index.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Attrition in drug discovery and development / Scott Boyer, Clive Brealey and Andrew M. Davis -- Compound attrition at the pre-clinical phase / Cornelis E.C.A. Hop -- Attrition in phase I / Dennis A. Smith and Thomas A. Baillie -- Compound attrition in phase II/III / Alexander Alex, C. John Harris, Wilma W. Keighley and Dennis A. Smith -- Post-marketing attrition / Dennis A. Smith -- Influence of the regulatory environment on attrition / Robert T. Clay -- Experimental screening strategies to reduce attrition risk / Marie-Claire Peakman, Matthew Troutman, Rose Gonzales and Anne Schmidt -- Medicinal chemistry strategies to prevent compound attrition / J. Richard Morphy -- Influence of phenotypic and target-based screening strategies on compound attrition and project choice / Andrew Bell, Wolfgang Fecke and Christine Williams -- In silico approaches to address compound attrition / Peter Gedeck, Christian Kramer, Richard Lewis -- Current and future strategies for improving drug discovery efficiency / Peter Mbugua Njogu and Kelly Chibale -- Impact of investment strategies,



organizational structure and corporate environment on attrition, and future investment strategies to reduce attrition / Geoff Lawton.